Hospira, Inc.  

(Public, NYSE:HSP)   Watch this stock  
Find more results for William Bowles�
87.84
+0.12 (0.14%)
Mar 31 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 87.72 - 87.91
52 week 42.01 - 88.09
Open 87.74
Vol / Avg. 940,968.00/2.39M
Mkt cap 15.12B
P/E 45.03
Div/yield     -
EPS 1.95
Shares 172.38M
Beta 0.70
Inst. own 93%
May 6, 2015
Hospira Inc Annual Shareholders Meeting - 12:00PM EDT - Add to calendar
Apr 28, 2015
Q1 2015 Hospira Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 12, 2015
Q4 2014 Hospira Inc Earnings Release
Feb 5, 2015
Pfizer Inc Discussing Proposed Acquisition of Hospira Call (Media)
Feb 5, 2015
Pfizer Inc Discussing Proposed Acquisition of Hospira Call (Analyst and Investor)
Jan 14, 2015
Hospira Inc at JPMorgan Healthcare Conference - Q&A Session
Jan 14, 2015
Hospira Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 3.03% 7.09%
Operating margin 3.52% 10.45%
EBITD margin - 18.27%
Return on average assets 2.08% 4.93%
Return on average equity 4.29% 10.58%
Employees 19,000 -
CDP Score - 58 E

Address

275 N Field Dr
LAKE FOREST, IL 60045-2579
United States - Map
+1-847-9376472 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hospira, Inc., provides injectable pharmaceutical drugs and infusion technologies that it develops, manufactures, distributes, and markets worldwide. The Company�s portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers, and long-term care facilities. The Company conducts operations worldwide and is managed in three segments: the Americas (such as the United States, Canada, and Latin America); Europe, the Middle East, and Africa (EMEA); and the Asia Pacific (APAC) (such as Asia, Japan, Australia, and New Zealand).

Officers and directors

F. Michael Ball Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Thomas E. Werner Senior Vice President - Finance, Chief Financial Officer
Age: 57
Bio & Compensation  - Reuters
David J. Endicott President of Hospira Medical Devices
Age: 50
Bio & Compensation  - Reuters
Kenneth F. Meyers Senior Vice President, Chief Human Resource Officer
Age: 53
Bio & Compensation  - Reuters
Mary A. Gendron Senior Vice President, Chief Information Officer
Age: 49
Bio & Compensation  - Reuters
Sumant Ramachandra M.D., Ph.D. Senior Vice President, Chief Scientific Officer
Age: 46
Bio & Compensation  - Reuters
Royce R. Bedward Senior Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Brian J. Smith Senior Vice President, Special Counsel
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard John Davies Senior Vice President, Chief Commercial Officer
Age: 53
Bio & Compensation  - Reuters
Zena G. Kaufman Senior Vice President - Quality
Age: 58
Bio & Compensation  - Reuters